The Malayalam web series Pharma, starring Nivin Pauly and Rajit Kapur in the lead roles, is directed by PR Arun. It began streaming on the JioHotstar OTT platform yesterday. The release attracted attention due to Nivin Pauly’s strong past box office record.
High expectations surrounded the project from the time of its announcement. However, early audience responses indicate disappointment. Viewers feel the series suffers mainly due to a weak and uneven screenplay.
Several viewers have shared that while the core plot of Pharma feels fresh and intriguing, the execution fails to hold interest. The flat narration reportedly turns a promising idea into an average viewing experience.
Social media reactions have also turned critical of Nivin Pauly’s recent career choices. Many users are advising him to select stronger scripts. They point out that none of his recent projects have delivered commercial success.
A few years ago, Nivin Pauly was among the most sought-after actors in Malayalam cinema. In recent times, however, his films have struggled to connect with audiences. Even moderately decent outings have failed to leave a lasting impact.
Following the mixed response to Pharma, Malayalam film trackers say his next big hope is Benz. In the film, Nivin Pauly plays the antagonist, and expectations are high as it is part of the Lokesh Kanagaraj Cinematic Universe (LCU).
The underwhelming reception to Pharma has reignited debate around Nivin Pauly’s career trajectory. Social media is filled with discussions on his box office slump, with many sharing opinions on whether he can reclaim his former market value.
